Drug profile

The FDA adverse-event record for Betamethasone Valerate + Gentamicin Sulfate

72 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Betamethasone Valerate + Gentamicin Sulfate. See the species affected, top reactions, and outcomes below.

72
adverse-event reports
0.0%
death-coded share
Unknown
most-reported species
17
Dispenser, Abnormal - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
72
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Betamethasone ValerateGentamicin Sulfate

Administration Routes

UnknownTopical

Species Affected

Unknown 64
Dog 4
Cat 3
Horse 1

Most Affected Breeds

Unknown 66
Russian 2
Pit Bull 1
Boxer (German Boxer) 1
Whippet 1
Quarter Horse 1

Most Reported Reactions

Dispenser, Abnormal 17
Applicator, Abnormal 13
Product Defect, General 11
Underfilling, Container 8
Bottles, Damaged 8
Defect Unknown/Not Specified 5
Containers, Damaged 3
Hives (see also 'Skin') 2
Containers, Leaking 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
Drooling 2
Swollen mouth 2

Outcome Breakdown

Recovered/Normal
6 (75.0%)
Ongoing
1 (12.5%)
Outcome Unknown
1 (12.5%)

Betamethasone Valerate + Gentamicin Sulfate Adverse Event Insights

72 reports name Betamethasone Valerate + Gentamicin Sulfate; 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredients: Betamethasone Valerate, Gentamicin Sulfate. Administration routes: Unknown, Topical.

By species: Unknown (64 reports), Dog (4 reports), Cat (3 reports). By breed: Unknown (66), Russian (2), Pit Bull (1).

Leading clinical signs: Dispenser, Abnormal (17), Applicator, Abnormal (13), Product Defect, General (11), Underfilling, Container (8). Outcome, 8 coded reports: Recovered/Normal leads at 75.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.